Robert Moot
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 6
- CAR-T cell therapy research 6
-
- Hemophilia Treatment and Research 3
- Co-authors
- H. Trent Spencer (10 shared papers)Christopher B. Doering (10 shared papers)Sunil S. Raikar (4 shared papers)Andrew Fedanov (1 shared paper)Christopher D. Porada (2 shared papers)Graça D. Almeida-Porada (2 shared papers)Esmail D. Zanjani (1 shared paper)Neal N. Iwakoshi (1 shared paper)
- Journals
- Blood (4 papers)Nature (2 papers)The Journal of Gene Medicine (1 paper)Gene Therapy (1 paper)OncoImmunology (1 paper)
- Partner nations
- United States
In The Last Decade
Robert Moot
12 papers receiving 559 citations
Robert Moot's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 355
- Immunology 201
- Hematology 57
- Genetics 131
- Molecular Biology 228
Countries citing papers authored by Robert Moot
This map shows the geographic impact of Robert Moot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Moot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Moot more than expected).
Fields of papers citing papers by Robert Moot
This network shows the impact of papers produced by Robert Moot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Moot. The network helps show where Robert Moot may publish in the future.
Co-authors
The 23 scholars most cited alongside Robert Moot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Non-viral precision T cell receptor replacement for personalized cell therapy Hit paper breakdown → | 2022 | 212 |
| 2 | 2023 | 124 | |
| 3 | 2017 | 74 | |
| 4 | 2011 | 54 | |
| 5 | 2010 | 38 | |
| 6 | 2016 | 29 | |
| 7 | 2014 | 18 | |
| 8 | 2014 | 10 | |
| 9 | 2017 | 10 | |
| 10 | 2015 | 5 | |
| 11 | 2010 | 4 | |
| 12 | 2015 | 2 |
About Robert Moot
Robert Moot is a scholar working on Oncology, Hematology, Immunology, Molecular Biology and Genetics, having authored 12 papers that have together received 580 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), CRISPR and Genetic Engineering (4 papers), Hemophilia Treatment and Research (3 papers), Immunotherapy and Immune Responses (2 papers), Virus-based gene therapy research (2 papers), Immune Cell Function and Interaction (2 papers), Microfluidic and Bio-sensing Technologies (1 paper) and Silicon Carbide Semiconductor Technologies (1 paper). The work is most often cited by research in Oncology (355 citations), Immunology (201 citations), Hematology (57 citations), Genetics (131 citations) and Molecular Biology (228 citations). Robert Moot has collaborated with scholars based in United States. Frequent co-authors include H. Trent Spencer, Christopher B. Doering, Sunil S. Raikar, Andrew Fedanov, Christopher D. Porada, Graça D. Almeida-Porada, Esmail D. Zanjani, Neal N. Iwakoshi, Shawn M. Jobe and Evan Joseph Colletti. Their work appears in journals such as Blood, Nature, The Journal of Gene Medicine, Gene Therapy and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.